• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性卵巢肿瘤囊液中可溶性E-钙黏蛋白水平高于良性囊肿。

Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts.

作者信息

Sundfeldt K, Ivarsson K, Rask K, Haeger M, Hedin L, Brännström M

机构信息

Department of Physiology, University of Göteborg, Box 434, S-405 30 Göteborg, Sweden.

出版信息

Anticancer Res. 2001 Jan-Feb;21(1A):65-70.

PMID:11299791
Abstract

A major diagnostic dilemma in the clinical gynaecological oncology setting is to preoperatively determine whether a complex ovarian mass is benign or malignant. The cell-cell adhesion molecule E-cadherin has previously been localised in biopsies from both benign and malignant epithelial ovarian tumours. In this study, soluble E-cadherin levels was measured with ELISA-technique in peripheral blood, ascites and cystic fluids from patients (n = 33) undergoing surgery for ovarian cystic masses. The levels of soluble E-cadherin were significantly higher in cystic fluid from cystadenocarcinomas (p < 0.001) and borderline tumours (p < 0.05) as compared to cystic fluid from cystadenomas. In ascites fluid and peripheral blood no significant differences were seen. However, ratios of cystic fluid/peripheral blood levels were significantly higher in cystadenocarcinoma (p < 0.001) and borderline tumours (p < 0.05) as compared to benign tumours. In conclusion, measurements of soluble E-cadherin in cystic fluid from patients presenting with complex ovarian masses may be beneficial in increasing the accuracy of preoperative diagnosis.

摘要

临床妇科肿瘤学中一个主要的诊断难题是在术前确定复杂的卵巢肿物是良性还是恶性。细胞间粘附分子E-钙粘蛋白此前已在良性和恶性上皮性卵巢肿瘤的活检组织中定位。在本研究中,采用ELISA技术测量了33例接受卵巢囊性肿物手术患者外周血、腹水和囊液中的可溶性E-钙粘蛋白水平。与囊腺瘤的囊液相比,囊腺癌(p < 0.001)和交界性肿瘤(p < 0.05)囊液中的可溶性E-钙粘蛋白水平显著更高。在腹水和外周血中未观察到显著差异。然而,与良性肿瘤相比,囊腺癌(p < 0.001)和交界性肿瘤(p < 0.05)的囊液/外周血水平比值显著更高。总之,测量出现复杂卵巢肿物患者囊液中的可溶性E-钙粘蛋白可能有助于提高术前诊断的准确性。

相似文献

1
Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts.恶性卵巢肿瘤囊液中可溶性E-钙黏蛋白水平高于良性囊肿。
Anticancer Res. 2001 Jan-Feb;21(1A):65-70.
2
Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.卵巢囊肿液中血管内皮生长因子水平与恶性肿瘤相关。
Clin Cancer Res. 1999 Apr;5(4):823-9.
3
Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.卵巢上皮性肿瘤患者血清及囊液中的促性腺激素(促黄体生成素、促卵泡生成素)水平。
Arch Gynecol Obstet. 2004 Nov;270(3):151-6. doi: 10.1007/s00404-003-0519-4. Epub 2003 Jul 23.
4
Increased concentrations of neopterin in plasma, ascites and ovarian cyst fluid in malignant tumours compared with benign ovarian tumours.
Anticancer Res. 1996 Sep-Oct;16(5B):3189-92.
5
Soluble adhesion molecules in serum and cyst fluid from patients with cystic tumours of the ovary.卵巢囊性肿瘤患者血清和囊液中的可溶性黏附分子
Hum Reprod. 1998 Oct;13(1O):2831-5. doi: 10.1093/humrep/13.10.2831.
6
Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer.全长和裂解形式的尿激酶型纤溶酶原激活物可溶性受体在卵巢癌囊液中高浓度存在。
Cancer Res. 1998 Aug 1;58(15):3294-8.
7
Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.卵巢癌患者血清、囊肿及腹水中CA125、组织多肽特异性抗原和可溶性白细胞介素-2受体α水平的比较分析。
Cancer. 2002 Nov 1;95(9):1886-93. doi: 10.1002/cncr.10917.
8
Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.血管内皮生长因子及其可溶性受体在卵巢良恶性肿瘤中的表达
Biomed Pharmacother. 2008 Jul-Aug;62(6):373-7. doi: 10.1016/j.biopha.2007.10.005. Epub 2007 Oct 30.
9
Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.卵巢癌患者囊液和血清中的钙粒蛋白
Cancer Res. 2003 Nov 1;63(21):7507-14.
10
Clinical value of components of the plasminogen activation system in ovarian cyst fluid.纤溶酶原激活系统各组分在卵巢囊肿液中的临床价值。
Anticancer Res. 2002 Jan-Feb;22(1A):275-82.

引用本文的文献

1
Matriptase drives dissemination of ovarian cancer spheroids by a PAR-2/PI3K/Akt/MMP9 signaling axis.组织蛋白酶 M 通过 PAR-2/PI3K/Akt/MMP9 信号通路促进卵巢癌细胞球的扩散。
J Cell Biol. 2023 Nov 6;222(11). doi: 10.1083/jcb.202209114. Epub 2023 Sep 22.
2
The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.金属蛋白酶及其内源性抑制剂的多方面作用:卵巢癌进展的研究视角。
Int J Mol Sci. 2018 Feb 2;19(2):450. doi: 10.3390/ijms19020450.
3
Cleavage of transmembrane junction proteins and their role in regulating epithelial homeostasis.
跨膜连接蛋白的裂解及其在调节上皮细胞稳态中的作用。
Tissue Barriers. 2013 Apr 1;1(2):e24783. doi: 10.4161/tisb.24783.
4
Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients.墨西哥患者腹水中岩藻糖基化触珠蛋白α亚型的蛋白质组学鉴定及其在卵巢癌组织中的定位
J Ovarian Res. 2014 Feb 27;7:27. doi: 10.1186/1757-2215-7-27.
5
Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ.定量蛋白质组学分析 iTRAQ 鉴定卵巢囊液中的潜在肿瘤标志物。
Clin Proteomics. 2013 Apr 4;10(1):4. doi: 10.1186/1559-0275-10-4.
6
Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers.卵巢囊液是一种富含蛋白质组的资源,可用于检测新的肿瘤生物标志物。
Clin Proteomics. 2012 Dec 27;9(1):14. doi: 10.1186/1559-0275-9-14.
7
Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells.溶血磷脂酸破坏卵巢癌细胞的连接完整性和上皮细胞黏附性。
J Oncol. 2012;2012:501492. doi: 10.1155/2012/501492. Epub 2012 Apr 22.
8
Activated epidermal growth factor receptor in ovarian cancer.卵巢癌中活化的表皮生长因子受体
Cancer Treat Res. 2009;149:203-26. doi: 10.1007/978-0-387-98094-2_10.
9
Soluble E-cadherin: an early marker of severity in acute pancreatitis.可溶性E-钙黏蛋白:急性胰腺炎严重程度的早期标志物。
HPB Surg. 2009;2009:397375. doi: 10.1155/2009/397375. Epub 2009 Apr 27.
10
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.基质金属蛋白酶9是卵巢癌细胞中表皮生长因子依赖性E-钙黏蛋白缺失的介质。
Cancer Res. 2008 Jun 15;68(12):4606-13. doi: 10.1158/0008-5472.CAN-07-5046.